ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

LIAN LianBio

0.319
0.00 (0.00%)
Pre Market
Last Updated: 19:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
LianBio LIAN NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 0.319 19:00:00
Open Price Low Price High Price Close Price Previous Close
0.319
more quote information »

Recent News

Date Time Source Heading
3/11/202406:51EDGAR2Form 25 - Notification of the removal from listing and..
2/28/202406:00GLOBELianBio Announces Voluntarily Delisting from Nasdaq
2/20/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/13/202406:04EDGAR2Form 8-K - Current report
2/13/202406:00GLOBELianBio Announces Completion of Strategic Review
1/08/202405:13EDGAR2Form 144 - Report of proposed sale of securities
12/29/202306:56EDGAR2Form 144 - Report of proposed sale of securities
12/26/202315:10EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/26/202315:07EDGAR2Form 8-K - Current report
12/26/202313:40APSBiotech Finds Success Following Holiday Weekend
12/26/202301:00GLOBELianBio Enters into Agreement Assigning its Rights for..
12/20/202307:05EDGAR2Form 8-K - Current report
12/20/202307:00GLOBELianBio Announces Departure of Chief Financial Officer
12/19/202315:26EDGAR2Form 8-K - Current report
12/19/202315:05GLOBELianBio Announces Departure of Chief Executive Officer
12/06/202315:23EDGAR2Form 8-K - Current report
12/06/202315:05GLOBELianBio’s Board of Directors Unanimously Determines not to..
12/01/202315:16EDGAR2Form 8-K - Current report
12/01/202315:05GLOBELianBio Confirms Receipt of Unsolicited Proposal from..
11/13/202315:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202315:17EDGAR2Form 8-K - Current report
11/13/202315:05GLOBELianBio Reports Third Quarter 2023 Financial Results and..
10/30/202315:16EDGAR2Form 8-K - Current report
10/30/202315:05GLOBELianBio Announces Topline Results from Phase 3 LIBRA Trial..
10/25/202315:05GLOBELianBio Announces Presentation of Data from Phase 2a Study..
10/24/202309:25APSBiotech Shares Soar Premarket
10/24/202308:22DJNLianBio Shares Soar Premarket on Strategic Review, End of..
10/24/202305:59GLOBELianBio Enters into Agreement with Bristol Myers Squibb for..
8/28/202315:05GLOBELianBio Announces Results from Phase 3 EXPLORER-CN Trial of..
8/14/202315:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/202315:11EDGAR2Form 8-K - Current report
8/14/202315:05GLOBELianBio Reports Second Quarter 2023 Financial Results and..
8/03/202315:05GLOBELianBio Announces First Patient Treated in Phase 1 Trial of..
7/26/202307:30GLOBELianBio Partner Tarsus Pharmaceuticals Announces U.S. FDA..
7/18/202307:00GLOBELianBio Partner NANOBIOTIX Enters into License Agreement..
7/17/202305:00GLOBELianBio Announces Phase 3 EXPLORER-CN Data Accepted for..
7/12/202307:00GLOBELianBio Announces Clinical Supply Agreement with AstraZeneca..
6/26/202307:00GLOBELianBio Announces Marketing Approval of CAMZYOS®..
6/08/202306:00GLOBELianBio Completes Enrollment in Pivotal Phase 3 LIBRA Trial..
6/07/202317:21DJNADRs End Mostly Lower, Oatly and LianBio Trade Actively
6/06/202315:05GLOBELianBio Announces Topline Results from Phase 2a Proof of..
6/01/202315:15GLOBELianBio to Participate in Upcoming Investor Conferences
5/11/202315:15GLOBELianBio Reports First Quarter 2023 Financial Results and..
5/11/202306:00GLOBELianBio Announces Marketing Approval of CAMZYOS®..

Your Recent History

Delayed Upgrade Clock